We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Companies Pool Interests to Develop Toponomics Platform

By Biotechdaily staff writers
Posted on 30 Jan 2003
A collaborative agreement to develop a new technology platform for managing the analysis of protein networks of whole cells in situ, known as topologic proteomics or toponomics, has been announced by MelTec GmbH (Magdeburg, Germany) and the Fraunhofer Institute for Applied Information Technology (FIT, Sankt Augustin, Germany). More...


Under the agreement, the two companies will work together to develop new software-based approaches to analyze and visualize protein networks and then correlate that data with results from in vitro and in vivo experiments. They will combine the robotic toponomics imaging technology of MelTec with the image management and proteomics software of FIT. The system will be designed to rapidly produce high-quality results for understanding how proteins impact a drug's effectiveness.

"Our alliance will allow us to create an integrated environment that enables biologists to quickly identify and validate functional aspects of living cells,” said Dr. Thomas Berlage, director of FIT.




Related Links:
MelTec
Fraunhofer Institute for Applied Information Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Pipette Calibration System
Artel PCS®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.